NASH (Non-Alcoholic Steatohepatitis)

An advanced form of fatty liver involving inflammation and liver damage—often driven by excess fructose metabolism.

Liver Health Starts with Energy Balance

NASH isn’t just about fat in the liver—it’s about the inflammation and mitochondrial dysfunction that follow.

Fructose metabolism plays a central role in NASH by rapidly generating fat, uric acid, and oxidative stress in liver cells. Over time, this leads to inflammation, scarring, and liver damage—even in the absence of alcohol. And because the polyol pathway can produce fructose endogenously, this damage can occur even on a sugar-free diet.

SugarShield is formulated to help support liver resilience by modulating the effects of excess fructose metabolism. It’s a science-driven approach to protecting cellular energy and metabolic health—before inflammation takes hold.

Explore SugarShield

What is NASH?

Non-Alcoholic Steatohepatitis (NASH) is a severe progression of non-alcoholic fatty liver disease (NAFLD), characterized not just by fat buildup but also by liver inflammation and cellular damage.

Symptoms and Risks

NASH may be silent in early stages but can lead to:
- Liver fibrosis and scarring
- Cirrhosis
- Liver failure or cancer

It's a rising cause of liver transplants worldwide.

Fructose and NASH

Fructose metabolism plays a key role in NASH:
- Promotes fat accumulation via de novo lipogenesis
- Elevates uric acid and oxidative stress
- Disrupts mitochondrial energy, triggering inflammation

Internal Production Risk

Even without sugar, endogenous fructose from carbs, alcohol, or salt can continue to fuel the NASH process—especially in metabolically compromised individuals.

At LIV3, we see NASH as a downstream effect of a broken energy pathway—and targeting fructokinase is a proactive step to prevent or reverse this damage at its metabolic root."

Related Articles

Luteolin: The Anti-Sugar Nutrient You’ve Never Heard Of (But Need to Know About)

Luteolin: The Anti-Sugar Nutrient You’ve Never Heard Of (But Need to Know About)

Luteolin is a rare plant flavonoid shown to naturally quiet the fructose pathway—the same metabolic switch targeted by pharmaceutical fructokinase inhibitors. By protecting cellular energy and lowering uric acid and inflammation, it helps restore the stable, high-efficiency metabolism that modern diets have lost.

Huntington’s Disease Breakthrough: Gene Therapy AMT-130 and the Energy Failure Model

Huntington’s Disease Breakthrough: Gene Therapy AMT-130 and the Energy Failure Model

A new gene therapy has slowed Huntington’s disease progression for the first time — a historic breakthrough. Seen through the energy failure model, it also highlights how metabolic stress like fructose stacks on top of genetic insults, and why research on luteolin is showing promise across multiple neurodegenerative conditions.

Tylenol, Autism Risk, and Fragile Energy: What Does the Science Really Say?

Tylenol, Autism Risk, and Fragile Energy: What Does the Science Really Say?

The Tylenol–autism debate shows how easily developing brains can be tipped when cellular energy is fragile. Our research suggests a bigger story: the Fructose Model — a framework showing how daily sugar exposure creates the same low-energy state across the whole body.

The Fructose–Insulin Connection: What Doctors Aren’t Telling You About Weight Loss Resistance

The Fructose–Insulin Connection: What Doctors Aren’t Telling You About Weight Loss Resistance

Doctors often blame carbs in general, but that's only part of the story. To really answer what causes insulin resistance, we need to look at fructose. If the engine is the problem, pressing harder on the gas pedal won't help. Instead, the solution is to improve how the cell handles fuel and gradually rebuild insulin sensitivity.

My Cart
0